02-07-2025
- Business
- AU Financial Review
Biotech start-up Aegros lives again after $37m rescue package
An Australian biotech start-up hoping to emulate the success of blood plasma giant CSL has secured a $37 million lifeline eight months after it was forced to suspend operations unable to repay mounting debts.
Staff at Aegros were stood down with pay in November when the company paused operations to search for funding. At the time, the company owed contractors and staff around $16 million. Development of a $65 million manufacturing facility expansion in Sydney has also been paused for a year.
